Leishmaniasis recidivans recurrence after 43 years: A clinical and immunologic report after successful treatment

Clinical Infectious Diseases

Volumn 33, Issue 7, 2001, Pages 1076-1079

  Marovich, Mary A ^a   Rosalia, Lira ^a   Shepard, M ^b   Fuchs, G H ^c   Kruetzer, R ^d   Nutman, T B ^a   Neva, F A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Departments of Medicine   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CD4 ANTIGEN; CD8 ANTIGEN; ITRACONAZOLE; STEROID; STIBOGLUCONATE SODIUM;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; IMMUNE RESPONSE; LEISHMANIA TROPICA; LEISHMANIASIS; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN BIOPSY; SYMPTOM; T LYMPHOCYTE;

ANIMALS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; HUMANS; ITRACONAZOLE; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; RECURRENCE; STEROIDS; TIME FACTORS;

EID: 0035478308     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/322643     Document Type: Article

References (11)

1. Leishmania Recidiva Cutis: Leishmanid
2. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process
3. Leishmania tropica: The identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease
4. The T cell phenotypes in the lesion of patients with cutaneous leishmaniasis
5. Study of T cell subsets in patients with cutaneous leishmaniasis
6. + T cells associated with cure of human cutaneous leishmaniasis
7. Leishmaniasis recidiva cutis in New World cutaneous leishmaniasis
8. Cutaneous leishmaniasis following local trauma: A clinical pearl
9. Wound healing: Aiming for perfect skin regeneration
10. Transforming growth factor-β in leishmanial infection: A parasite escape mechanism
11. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by Th3/Tr1-type cytokines IL-10 and transforming growth factor-β but not by a Th1 to Th2 shift